[go: up one dir, main page]

TW200616971A - Condensed tricyclic benzimidazoles - Google Patents

Condensed tricyclic benzimidazoles

Info

Publication number
TW200616971A
TW200616971A TW094134552A TW94134552A TW200616971A TW 200616971 A TW200616971 A TW 200616971A TW 094134552 A TW094134552 A TW 094134552A TW 94134552 A TW94134552 A TW 94134552A TW 200616971 A TW200616971 A TW 200616971A
Authority
TW
Taiwan
Prior art keywords
condensed tricyclic
tricyclic benzimidazoles
benzimidazoles
gastric
condensed
Prior art date
Application number
TW094134552A
Other languages
English (en)
Inventor
Christof Brehm
Peter Jan Zimmermann
Wilm Buhr
M Vittoria Chiesa
Andreas Palmer
Stefan Postius
Wolfgang Kromer
Wolfgang-Alexander Simon
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of TW200616971A publication Critical patent/TW200616971A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW094134552A 2004-10-04 2005-10-03 Condensed tricyclic benzimidazoles TW200616971A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04104851 2004-10-04

Publications (1)

Publication Number Publication Date
TW200616971A true TW200616971A (en) 2006-06-01

Family

ID=34929655

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094134552A TW200616971A (en) 2004-10-04 2005-10-03 Condensed tricyclic benzimidazoles

Country Status (7)

Country Link
US (1) US20080113962A1 (zh)
EP (1) EP1799681A1 (zh)
AR (1) AR051041A1 (zh)
AU (1) AU2005291295A1 (zh)
CA (1) CA2582294A1 (zh)
TW (1) TW200616971A (zh)
WO (1) WO2006037759A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365560T3 (es) * 2006-09-21 2011-10-06 Raqualia Pharma Inc Derivados de bencilmidazoles como inhibidores selectivos de bombas de ácido.
WO2008035195A1 (en) * 2006-09-21 2008-03-27 Raqualia Pharma Inc. Benzimidazole derivatives as selective acid pump inhibitors
WO2008114123A1 (en) * 2007-03-21 2008-09-25 Raqualia Pharma Inc. Spiro benzimidazole derivatives as acid pump inhibitors
MX2012000275A (es) 2009-07-09 2012-02-08 Raqualia Pharma Inc Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
EP2877461B1 (en) * 2012-07-27 2018-05-09 Emory University Heterocyclic flavone derivatives, compositions, and methods related thereto
SG10202100916PA (en) 2015-02-02 2021-02-25 Valo Early Discovery Inc 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
WO2016126726A1 (en) 2015-02-02 2016-08-11 Forma Therapeutics, Inc. Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors
WO2017218950A1 (en) 2016-06-17 2017-12-21 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors
TW202432120A (zh) * 2023-02-01 2024-08-16 韓商安康尼克治療有限公司 注射用組合物、包含其之醫藥調配物以及製備該組合物之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
SE9602286D0 (sv) * 1996-06-10 1996-06-10 Astra Ab New compounds
EP1419163B9 (en) * 2001-08-10 2005-11-09 ALTANA Pharma AG Tricyclic imidazopyridines

Also Published As

Publication number Publication date
US20080113962A1 (en) 2008-05-15
AR051041A1 (es) 2006-12-13
CA2582294A1 (en) 2006-04-13
AU2005291295A1 (en) 2006-04-13
WO2006037759A1 (en) 2006-04-13
EP1799681A1 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
TW200504031A (en) 6-substituted benzimidazoles
TW200718422A (en) 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
TW200510410A (en) Cyclic benzimidazoles
DE502008001158D1 (en) Benzimidazolderivate
SI1419163T1 (sl) Triciklicni imidazopiridini
TW200616971A (en) Condensed tricyclic benzimidazoles
EA200300478A1 (ru) Полизамещенные имидазопиридины в качестве ингибиторов желудочной секреции
TW200700064A (en) Novel compounds
TW200504068A (en) 6-substituted imidazopyrazines
TW200602326A (en) Tricyclic imidazopyridines
MXPA05005117A (es) Imidazopiridinas 8-sustituidas.
NO20080144L (no) Spiro-benzimidazoler som inhibitorer av magesyre og sekresjon
TW200611903A (en) Substituted tricyclic benzimidazoles
TW200600502A (en) Novel 6-substituted benzimidazoles
WO2006037748A8 (en) Substituted tricyclic benzimidazoles
WO2005058893A8 (en) Tricyclic benzimidazoles
WO2008095912A3 (en) Enantiopure pharmacologically active tricyclic benzimidazoles
TW200630373A (en) Difluoro-substituted imidazopyridines
WO2008071766A3 (en) Spiro-indene substituted imidazonaphythyridine and pyranoimidazopyridine derivatives as inhibitors of gastric acid secretion
TW200603801A (en) Novel dialkoxy-imidazopyridines
TW200613301A (en) Novel amino-halogen-imidazopyridines
TW200716637A (en) Pharmaceutically active spiro-imidazopyridines
MX2010004469A (es) Compuestos de fenilpirrolidina.
UA91250C2 (en) 4-oxadiazolyl-piperidine compounds and use thereof
UA87793C2 (ru) 3-амино-1,1,1-трифторопропан-2-сульфонат натрия